НовостиBenzingaTruist Securities Maintains Buy on Beta Bionics, Raises Price Target to $28 Truist Securities Maintains Buy on Beta Bionics, Raises Price Target to $28 Benzinga 2026.09.24 15:39 (GMT+0) Открыть на Benzinga Другие новости